©WebNovelPub
Previous chapter:
Chapter 617 The Original Capital Exit
PREVIEW
... nese investors.
However, the major investment companies remained calm, issuing statements expressing their confidence in the company. They claimed to have sent representatives to Africa to inspect the trials, assuring everyone that there was no risk.
Indeed, Hans Biopharmaceutical's performance didn't disappoint. News trickled in from Africa about the successful Phase III trials, which were soon to conclude before transitioning to trials in the U.S.
With these updates, Ha ...
YOU MAY ALSO LIKE